Global PrEP Network

WHO

Global state of PrEP

The WHO Global HIV Programme aims to provide up-to-date information on PrEP use and the adoption of the WHO recommendations on PrEP into national guidelines around the world. The data provided here were verified with countries where possible. If you have any further information on the data provided here, please contact the WHO PrEP team (hivprep@who.int) so that we can ensure our data are as accurate as possible.

Numbers of PrEP users

In 2023, more than 3.5 million people received PrEP at least once. Over 75% of these (2.6 million) were in the African region.

While the number of people who received PrEP increased by 35% between 2022 and 2023, these numbers are still below the target of 10 million people using PrEP by 2025.

Source: The Urgency of Now: UNAIDS 2024 Global AIDS Report

Number of people who received PrEP, by WHO region (2019-2023)

Full data on numbers of people who used PrEP by region and country is available from AIDSinfo, Global data on HIV epidemiology and response, a dashboard which presents data from the Global AIDS Monitoring (GAM) process, a collaboration of UNAIDS, WHO, and UNICEF.

For PrEP data, browse to section "Combination prevention".

Adoption of WHO PrEP recommendations in national guidelines

94%	of reporting countries (152 of 162) have already adopted WHO recommendations on pre-exposure prophylaxis (PrEP) in their national guidelines.
10	countries reported that their national guidelines do not recommend any PrEP products.
12	countries have adopted policies for injectable long-acting cabotegravir (CAB-LA) for prevention.
10	countries have adopted policies for the dapivirine vaginal ring (DVR).